Sunday, February 28, 2021 10:12:24 AM
CLWD share price of .08 times an O/S total of 915,073,664 equals a Market Cap of 73,205,893 divided by a TTM (trailing-twelve-month) revenue total of 10.39M equates to a price-to-sales ratio of (7).
You can't even come across this type of value on major exchanges take the leader in the space for instance Trade Desk which trades on the Nasdaq they have a current price-to-sales ratio of (41) and as far as the OTC goes the majority of the equities have TTM revenues of less than a million if any at all and have price-to-sales multiples in triple digits.
One of the market trends playing out over the last few months has been the money flow into penny stocks. Everyone has heard the aphorism ("A rising tide lifts all boats"), well that's what is transpiring in OTC land and I expect the trend to continue well into 2021. When you factor in new influences having major effects whether it be "Wall Street Bets" or "Stimulus Checks" it all comes down to directed money flow. Ultimately, that is the main driving force behind any ascending share price.
Those stocks such as CLWD being so well position in terms of value will be more prone to parabolic movements to the upside.
Recent AIAD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 10:45:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:35:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:50:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:50:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:49:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:48:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 06:28:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/20/2023 08:29:14 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:05:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 09:00:58 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM